Scan to Download
One power score. Smarter investment decisions
Revelation Biosciences Inc
REVB1.540USD
-0.020-1.28%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
787.78KMarket Cap
LossP/E TTM
Revelation Biosciences Inc
1.540
-0.020-1.28%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q1
FY2020Q4
FY2020Q3
Operating expenses
-2.42%2.46M
10.14%2.09M
-24.59%1.75M
-35.32%1.80M
30.49%2.52M
17.43%1.90M
90.91%2.33M
131.59%2.78M
3.90%1.93M
-75.41%1.62M
-68.41%1.22M
-60.60%1.20M
--1.86M
152.57%6.59M
136.72%3.86M
313.37%3.04M
--2.61M
--1.63M
--736.37K
R&D expenses
-5.52%1.32M
19.68%858.83K
-42.88%605.50K
-49.68%830.98K
53.41%1.39M
36.61%717.58K
211.79%1.06M
332.79%1.65M
-6.80%909.28K
-85.73%525.27K
-87.25%339.97K
-75.11%381.57K
--975.58K
136.36%3.68M
128.79%2.67M
241.33%1.53M
--1.56M
--1.17M
--449.06K
Depreciation, depletion, and amortization
0.00%7.22K
15.31%7.22K
15.31%7.22K
15.30%7.22K
15.30%7.22K
-0.02%6.26K
0.00%6.26K
0.00%6.26K
0.00%6.26K
0.02%6.26K
0.00%6.26K
3.15%6.26K
--6.26K
875.39%6.26K
--6.26K
--6.07K
--642.00
--0.00
--0.00
Operating profit
2.42%-2.46M
-10.14%-2.09M
24.59%-1.75M
35.32%-1.80M
-30.49%-2.52M
-17.43%-1.90M
-90.91%-2.33M
-131.59%-2.78M
-3.90%-1.93M
75.41%-1.62M
68.41%-1.22M
60.60%-1.20M
---1.86M
-152.57%-6.59M
-136.72%-3.86M
-313.37%-3.04M
---2.61M
---1.63M
---736.37K
Net non-operating interest income (expenses)
Special income (expenses)
-99.00%44.00
-97.93%1.42K
-96.25%2.56K
-93.47%6.04K
-98.96%4.42K
-99.12%68.43K
--68.20K
--92.56K
--423.24K
--7.74M
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
100.29%16.80K
105.01%42.48K
-53.25%25.61K
-891.64%-450.92K
-9628.96%-5.87M
-2585.48%-847.72K
410.05%54.78K
98.27%56.96K
139.45%61.62K
212.78%34.11K
412.33%10.74K
5257.63%28.73K
--25.73K
-551.46%-30.24K
-4194.05%-3.44K
---557.00
---4.64K
--84.00
--0.00
Income before tax
70.86%-2.44M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
---2.61M
---1.63M
---736.37K
Income after tax
70.86%-2.44M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
---2.61M
---1.63M
---736.37K
Net income from continuous operations
70.86%-2.44M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
---2.61M
---1.63M
---736.37K
Net income attributable to controlling interests
32.94%-5.63M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
---2.61M
---1.63M
---736.37K
Preferred share dividend
--3.18M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to common shareholders
32.94%-5.63M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
---2.61M
---1.63M
---736.37K
Basic earnings per share
74.38%-21.03
83.91%-6.33
96.78%-4.96
93.32%-13.38
31.36%-82.09
-102.94%-39.37
80.97%-154.16
78.55%-200.34
90.87%-119.60
128.32%1.34K
70.61%-809.88
57.02%-934.08
---1.31K
-153.28%-4.72K
-136.95%-2.76K
-313.39%-2.17K
---1.86K
---1.16K
---525.67
Diluted earnings per share
74.38%-21.03
83.91%-6.33
96.78%-4.96
93.32%-13.38
31.36%-82.09
-104.18%-39.37
80.97%-154.16
78.55%-200.34
90.87%-119.60
119.96%942.76
70.61%-809.88
57.02%-934.08
---1.31K
-153.28%-4.72K
-136.95%-2.76K
-313.39%-2.17K
---1.86K
---1.16K
---525.67
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
